News & Analysis on Clinical Trial Services & Contract Research And Development
By Natalie Morrison
- Last updated on
Rocci first joined the contract research organisation (CRO) in 2008, when it acquired Prevalere Life Sciences where he was serving as CEO.
Since the takeover, he has led Icon’s global bioanalytical business.
Peter Gray, CEO at Icon, said: "Mario has done an excellent job in building and shaping our bioanalytical capabilities and under his tenure we have been successful in forming strategic partnerships in this area with some large pharma clients.”